Tumour evolution in hepatocellular carcinoma

By Amanda J. Craig, J. von Felden, Teresa Garcia-Lezana, S. Sarcognato, A. Villanueva. Nature reviews: Gastroenterology & hepatology, 2019

699 citations recorded by the source corpus.

Subfields: Cancer Research, Hepatology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/77b371eb3bd05fac0a6b6704debcdf7feb93ef27

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Wan-Cheng Yang
2. Zhongyin Wei
3. Yinfeng Yang
4. Jinghui Wang
5. Jinling Huang
6. Shan Qian

Citations in the corpus

• The role of BCL-2 family proteins in regulating apoptosis and cancer therapy (2022, background): “Hepatocellular carcinoma (HCC) is the second largest cancer-related death (112); the 5-year survival rate is only 18% (113), characterized by high mortality, strong invasiveness, low sensitivity to chemotherapy drugs, and easy resistance (114).”